Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, October 17, 2013
Pharmaceutical contract development and manufacturing organizations (CDMOs) DPT Laboratories, based in San Antonio, Texas, and Confab, based in Saint-Hubert, Quebec, today announced the integration of the organizations under the leadership of Paul ...
read more
ClinTec International’s founder and CEO, Dr Rabinder Buttar, won the prestigious ‘Female Entrepreneur of the Year’ award at the Scottish Business Awards 2013 held at the Edinburgh International Conference Centre on Friday night. The awards, which are...
read more
Wednesday, September 19, 2012
Vince & Associates Clinical Research announced it has been awarded a contract with the National Institute on Drug Abuse, part of the National Institutes of Health (NIH), to carry out clinical pharmacology studies to determine the pharmacokinetics and...
read more
Recursion Pharmaceuticals announced it has hired Dr. Chand Sishta as the senior director of regulatory affairs.
read more
Rho, a contract research organization (CRO) focused on bringing new products to market through a full range of product development services, today announced that Dr. Jack Modell has joined its team as their senior medical officer, bringing 20 years ...
read more
Tuesday, January 15, 2019
Pharmaceutics International, Inc. (Pii) announced the appointment of Kurt R. Nielsen, Ph.D., to the position of President and CEO, effective immediately.
read more
Shanghai ChemPartner announced the appointment of Lilly Xu, Ph.D. as Vice President and the Head of DMPK and Exploratory Toxicology at the company headquarters.
read more
Friday, December 28, 2018
Dr. Reddy’s announced the launch of Sevelamer Carbonate for Oral Suspension, in 0.8 g and 2.4 g packets, a therapeutic equivalent generic version of Renvela.
read more
Dr. Reddy’s Laboratories announced the launch of Daptomycin for Injection, 500mg/vial single-dose vial, a therapeutic equivalent generic version of Cubicin® for Injection.
read more
Wednesday, September 11, 2019
Dr. Reddy’s Laboratories has announced the launch of Fosaprepitant for Injection, the therapeutic generic equivalent of EMEND® for injection, approved by the FDA.
read more
Dr. Reddy’s announced the launch of Carboprost Tromethamine Injection USP Single-dose Vial, a therapeutic equivalent generic version of Hemabate®, 250 mcg/mL, approved by the FDA.
read more
Thursday, February 21, 2019
Dr. Reddy’s announced the re-launch of its Buprenorphine and Naloxone Sublingual Film, a therapeutic equivalent generic version of Suboxone sublingual film, in the U.S. market.
read more
Dr. Reddy’s Laboratories has entered into a definitive agreement for the sale of its API manufacturing business unit located in Jeedimetla, Hyderabad, to Therapiva Private, a generics pharmaceutical company.
read more
Following a 15-year career with the company, Abhijit Mukherjee, Chief Operating Officer, will retire on March 31, 2018.
read more
Wednesday, October 31, 2018
Dr. Reddy’s Laboratories announced the launch of Atomoxetine Capsules, USP, a therapeutic equivalent generic version of Stratter (atomoxetine) Capsules in the United States.
read more